News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IMRIS CFO to Present at Canaccord Cardiovascular Conference



12/5/2011 12:12:23 PM

WINNIPEG, Dec. 5, 2011 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that Kelly McNeill, IMRIS Chief Financial Officer will present at the Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference on December 6, 2011 at 3:00 pm Pacific Time. An audio webcast of Mr. McNeill's presentation will be available at www.imris.com.

About IMRIS

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular and cerebrovascular markets and have been selected by leading medical institutions around the world.

SOURCE IMRIS Inc.


Read at BioSpace.com


comments powered by Disqus
IMRIS
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES